Skip to content

SG&A at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$12.33M-35.3%
ADMA Biologics logo
ADMA BiologicsADMA
$26.74M+11.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$163.9M+54.1%
Precigen logo
PrecigenPGEN
$21.05M+70.3%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$94.55M+14.7%
Abbott logo
AbbottABT
$3.74B+22.2%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's SG&A?
Absci Corporation (ABSI) reported SG&A of $9.06M in Q1 2026.
How has Absci Corporation's SG&A changed year-over-year?
Absci Corporation's SG&A decreased by 4.4% year-over-year, from $9.47M to $9.06M.
What is the long-term trend for Absci Corporation's SG&A?
Over 4 years (2021 to 2025), Absci Corporation's SG&A has grown at a 5.1% compound annual growth rate (CAGR), from $28.78M to $35.06M.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.